High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation

Blood

Volumn 110, Issue 13, 2007, Pages 4576-4583

  Lee, Stephanie J ^a   Klein, John ^b   Haagenson, Michael ^c   Baxter Lowe, Lee Ann ^d   Confer, Dennis L ^e   Eapen, Mary ^b   Fernandez Vina, Marcelo ^f   Flomenberg, Neal ^g   Horowitz, Mary ^b   Hurley, Carolyn K ^h   Noreen, Harriet ⁱ   Oudshoorn, Machteld ^j   Petersdorf, Effie ^a   Setterholm, Michelle ^e   Spellman, Stephen ^e   Weisdorf, Daniel ^k   Williams, Thomas M ^l   Anasetti, Claudio ^m  

^a Fred Hutchinson Cancer Research Center   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c CENTER FOR INTERNATIONAL BLOOD AND MARROW TRANSPLANT RESEARCH   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e NATIONAL MARROW DONOR PROGRAM   (United States)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^g THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^h GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF MINNESOTA MEDICAL CENTER   (United States)

^j Europdonor Foundation   (Netherlands)

^k UNIVERSITY OF MINNESOTA   (United States)

^l UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^m H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DPA1 ANTIGEN; HLA DPB1 ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; UNCLASSIFIED DRUG; DNA;

ADULT; ALLELE; ARTICLE; BLOOD DONOR; BONE MARROW TRANSPLANTATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOMEGALOVIRUS; DONOR; FEMALE; GENE LOCUS; HLA MATCHING; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; SURVIVAL; SURVIVAL RATE; UNITED STATES; ADOLESCENT; AGED; CHILD; GENETICS; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TEST; INFANT; METHODOLOGY; MIDDLE AGED; PRESCHOOL CHILD; REGISTER; RETROSPECTIVE STUDY; STANDARD; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ALLELES; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; DNA; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; INFANT; MIDDLE AGED; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL RATE; TISSUE DONORS; TREATMENT OUTCOME;

EID: 37349118061     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2007-06-097386     Document Type: Article

References (20)

1. Flomenberg N, Baxter-Lowe LA, Confer D, et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood. 2004;104:1923-1930.
2. Petersdorf EW, Gooley TA, Anasetti C, et al. Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood. 1998;92:3515-3520.
3. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation. 1974;18:295-304.
4. Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man: a long-term clinicopathologic study of 20 Seattle patients. Am J Med. 1980;69:204-217.
5. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18:695-706.
6. Klein JP, Moeschberger ML. Survival Analysis: Statistical Methods for Censored and Truncated Data. New York, NY: Springer-Verlag; 2003. 7. Morishima Y, Sasazuki T, Inoko H, et al. The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors. Blood. 2002;99:4200-4206.
7. Petersdorf EW, Malkki M, Gooley TA, Martin PJ, Guo Z. MHC haplotype matching for unrelated hematopoietic cell transplantation. PLoS Med. 2007;4:59-68.
8. Kawase T, Morishima Y, Matsuo K, et al. High-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease and implication for its molecular mechanism. Blood. Prepublished on June 6, 2007, as DOI 10.1182/blood-2007-02-072405. (Now available as Blood. 2007;110:2235-2241.)
9. Petersdorf EW, Smith AG, Mickelson EM, et al. The role of HLA-DPB1 disparity in the development of acute graft-versus-host disease following unrelated donor marrow transplantation. Blood. 1993;81:1923-1932.
10. Petersdorf EW, Gooley T, Malkki M, et al. The biological significance of HLA-DP gene variation in haematopoietic cell transplantation. Br J Haematol. 2001;112:988-994.
11. Shaw BE, Marsh SG, Mayor NP, Russell NH, Madrigal JA. HLA-DPB1 matching status has significant implications for recipients of unrelated donor stem cell transplants. Blood. 2006;107:1220-1226.
12. Sasazuki T, Juji T, Morishima Y, et al. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor: Japan Marrow Donor Program. N Engl J Med. 1998;339:1177-1185.
13. Petersdorf EW, Anasetti C, Martin PJ, et al. Limits of HLA mismatching in unrelated hematopoietic cell transplantation. Blood. 2004;104:2976-2980.
14. Tiercy JM, Passweg J, van Biezen A, et al. Isolated HLA-C mismatches in unrelated donor transplantation for CML. Bone Marrow Transplant. 2004;34:249-255.
15. Greinix HT, Fae I, Schneider B, et al. Impact of HLA class I high-resolution mismatches on chronic graft-versus-host disease and survival of patients given hematopoietic stem cell grafts from unrelated donors. Bone Marrow Transplant. 2005;35:57-62.
16. Hurley CK, Fernandez-Vina M, Hildebrand WH, et al. A high degree of HLA disparity arises from limited allelic diversity: analysis of 1775 unrelated bone marrow transplant donor-recipient pairs. Hum Immunol. 2007;68:30-40.
17. Petersdorf EW, Longton GM, Anasetti C, et al. The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation. Blood. 1995;86:1606-1613.
18. Petersdorf EW, Kollman C, Hurley CK, et al. Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program Experience. Blood. 2001;98:2922-2929.
19. Ho VT, Kim HT, Liney D, et al. HLA-C mismatch is associated with inferior survival after unrelated donor non-myeloablative hematopoietic stem cell transplantation. Bone Marrow Transplant. 2006;37:845-850.
20. Kollman C, Howe CW, Anasetti C, et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood. 2001;98:2043-2051.